MORGAN STANLEY - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$18,756,948
+34.9%
5,239,371
+39.0%
0.00%
+100.0%
Q2 2023$13,905,462
-5.9%
3,768,418
-15.6%
0.00%
-50.0%
Q1 2023$14,782,797
+18.0%
4,466,102
+38.3%
0.00%
+100.0%
Q4 2022$12,525,945
+118.6%
3,228,336
+36.9%
0.00%0.0%
Q3 2022$5,729,000
+236.8%
2,357,621
+174.5%
0.00%
Q2 2022$1,701,000
+608.8%
858,763
+553.6%
0.00%
Q1 2022$240,000
-45.0%
131,386
-57.6%
0.00%
Q4 2021$436,000
-39.5%
310,029
-51.4%
0.00%
Q3 2021$721,000
+7.0%
638,534
+51.8%
0.00%
Q2 2021$674,000
+0.6%
420,606
+10.5%
0.00%
Q1 2021$670,000
+67.1%
380,576
+85.0%
0.00%
Q4 2020$401,000
-32.7%
205,724
-17.5%
0.00%
Q3 2020$596,000
-0.5%
249,212
+21.8%
0.00%
Q2 2020$599,000
+227.3%
204,529
+222.9%
0.00%
Q1 2020$183,000
-57.4%
63,333
-41.0%
0.00%
Q4 2019$430,000
+69.3%
107,306
+88.1%
0.00%
Q3 2019$254,000
+85.4%
57,052
+61.7%
0.00%
Q2 2019$137,000
-7.4%
35,282
-9.6%
0.00%
Q1 2019$148,000
-3.9%
39,014
-39.6%
0.00%
Q4 2018$154,000
-63.2%
64,552
-4.1%
0.00%
Q3 2018$418,000
+92.6%
67,317
+39.7%
0.00%
Q2 2018$217,000
+267.8%
48,180
+270.3%
0.00%
Q1 2018$59,000
+391.7%
13,011
+244.8%
0.00%
Q4 2017$12,000
-20.0%
3,774
-22.4%
0.00%
Q3 2017$15,000
-51.6%
4,863
-41.0%
0.00%
Q2 2017$31,000
-61.2%
8,237
-50.0%
0.00%
Q1 2017$80,000
-4.8%
16,4740.0%0.00%
Q4 2016$84,000
+35.5%
16,474
+93.0%
0.00%
Q3 2016$62,000
+12.7%
8,537
-6.7%
0.00%
Q2 2016$55,000
-27.6%
9,152
-3.1%
0.00%
Q1 2016$76,000
+46.2%
9,441
+46.3%
0.00%
Q4 2015$52,0000.0%6,452
+4.9%
0.00%
Q3 2015$52,000
+20.9%
6,152
+32.9%
0.00%
Q2 2015$43,000
+290.9%
4,628
+297.3%
0.00%
Q1 2015$11,000
+57.1%
1,165
+74.9%
0.00%
Q4 2014$7,0006660.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders